Jan 7 (Reuters) - Medicure Inc MPH.V :
* MEDICURE ANNOUNCES PIVOTAL PHASE 3 TRIAL IND FILING WITH FDA FOR TREATMENT OF SEIZURES ASSOCIATED WITH PYRIDOX(AM)INE 5'-PHOSPHATE OXIDASE (PNPO) DEFICIENCY
Jan 7 (Reuters) - Medicure Inc MPH.V :
* MEDICURE ANNOUNCES PIVOTAL PHASE 3 TRIAL IND FILING WITH FDA FOR TREATMENT OF SEIZURES ASSOCIATED WITH PYRIDOX(AM)INE 5'-PHOSPHATE OXIDASE (PNPO) DEFICIENCY